:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Yuanchu J. Yang, Chenjie Zeng, Kerry R. Schaffer, Tam C. Tran, Peter J. Sauer, Lincoln A. Brown, Ben H. Park, Joshua C. Denny
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	The Prostate
Online Access:	https://onlinelibrary.wiley.com/doi/10.1002/pros.24913
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Corticosteroid Use and Risk of Adverse Events in Metastatic Hormone‐Sensitive Prostate Cancer
by: Umang Swami, et al.
Published: (2026)

Impact of Concomitant Hormone Therapy on the Diagnostic Performance of 18F‐Piflufolastat PET/CT in Prostate Cancer Patients: A Sub‐Group Analysis of OSPREY Cohort B
by: Lawrence Saperstein, et al.
Published: (2025)

Efficacy and Predictive Factors Analysis of Androgen Deprivation Plus Novel Hormone Therapy as Neoadjuvant Treatment for High‐Risk Prostate Cancer
by: Hanyang Tao, et al.
Published: (2024)

Prognostic Impact of Initial Prostate Specific Antigen Half‐Life After Abiraterone Acetate in High‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: Who May Need Triplet Therapy?
by: Kotaro Suzuki, et al.
Published: (2026)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
by: Christian Andrés Martínez Osorio, et al.
Published: (2025)

The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone‐Sensitive Prostate Cancer Treated With First‐Line ARPI Therapy
by: Takeshi Tsutsumi, et al.
Published: (2026)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
by: Elizabeth Robinson, et al.
Published: (2025)

Comparison of Prognosis and Health‐Related Quality of Life Between Robot‐Assisted Radical Prostatectomy Versus High‐Dose‐Rate Brachytherapy Combined With External Beam Radiation Therapy and Hormone Therapy for High‐Risk Prostate Cancer
by: Yuya Iwahashi, et al.
Published: (2024)

Bone Metastasis Distribution Matters: Prognostic Effect of the Axial‐to‐Peripheral Ratio in Metastatic Hormone‐Sensitive Prostate Cancer
by: Ali Fuat Gürbüz, et al.
Published: (2026)

Prognostic Nutritional Index as a Biomarker in Metastatic Hormone‐Sensitive Prostate Cancer: Impact on Survival and Treatment Optimization
by: Muhammet Bekir Hacioglu, et al.
Published: (2025)

Safety and Efficacy of Intra‐Prostatic Injection of Betamethasone for Refractory Chronic Nonbacterial Prostatitis: A Prospective Cohort Clinical Study
by: Ahmed Yehia Abdelaziz, et al.
Published: (2024)

The Clinical Significance of Gallium‐68 PSMA‐11 PET‐Derived SUVmax in the Management of Metastatic Hormone‐Sensitive Prostate Cancer
by: Cevat İlteriş Kıkılı, et al.
Published: (2026)

Evaluating the Heterogeneity of Advanced Prostate Cancer by 18F‐DCFPyL and 18F‐FDG PET/CT in a Prospective Cohort
by: GuangHao Chen, et al.
Published: (2025)

Androgen Deprivation Therapy: Mitochondrial Dysfunction and Metabolic Impacts in Prostate Cancer
by: Yu‐Hsiang Lin, et al.
Published: (2025)

Real‐World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: A Propensity‐Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence Synthesis
by: Yosuke Yasuda, et al.
Published: (2026)

Hormone Therapy With Salvage Radiotherapy After Radical Prostatectomy: A Systematic Review and Meta‐Analysis
by: Reyhaneh Bayani, et al.
Published: (2025)

Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes
by: Christian P. Pavlovich, et al.
Published: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
by: Sheila Jonnatan, et al.
Published: (2026)

Outcome of Subsequent Therapies After 177Lu‐Vipivotide Tetraxetan for Metastatic Castrate‐Resistant Prostate Cancer: A Tertiary Cancer Center Experience
by: Meryam Losee, et al.
Published: (2025)

pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy
by: Piotr Bialas, et al.
Published: (2024)

Deciphering Resistance: Beyond the Androgen Paradigm; Report From the 2025 Coffey‐Holden Prostate Cancer Academy Meeting
by: Tanya Stoyanova, et al.
Published: (2025)

Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection
by: Reid Vassallo, et al.
Published: (2025)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
by: Andrea K. Miyahira, et al.
Published: (2024)

A Two‐Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone‐Sensitive Prostate Cancer
by: Koichiro Kurokawa, et al.
Published: (2026)

Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta‐Analysis of a Potential Therapeutic Target
by: Jacky T. F. Luk, et al.
Published: (2026)

Global Trends in Prostate Cancer Incidence Among Men Aged 55+ (1992–2021): An Age‐Period‐Cohort Analysis
by: Xinling Han, et al.
Published: (2026)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
by: Cameron J. Britton, et al.
Published: (2025)

The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
by: Trevor C. Hunt, et al.
Published: (2025)

Refining the CHAARTED Classification: Clinical Utility of a Novel Integrated Risk Stratification Model Incorporating Gleason Grade and Biochemical Markers in Japanese Patients With Metastatic Hormone‐Sensitive Prostate Cancer
by: Takanori Tokunaga, et al.
Published: (2025)

Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High‐Risk Metastatic Hormone‐Naïve Prostate Cancer: Results From a 3‐Year Interim Analysis of the J‐ROCK Study
by: Atsushi Mizokami, et al.
Published: (2026)

Challenging the Evolving Nomenclature of Ultrasound‐Guided Transperineal Prostate Biopsy: A Call for Standardization
by: Pedro Ivo C. Ravizzini, et al.
Published: (2026)

Racial Disparities in the Use of MRI and PET Scan Among Medicare Beneficiaries With Prostate Cancer
by: Hanna Zurl, et al.
Published: (2025)

Directed Evolution Restored Castrate Sensitivity in a Patient With Castrate Resistant Metastatic Prostate Cancer
by: Robert A. Gatenby, et al.
Published: (2025)

Prostate Volume and PSA‐Density Estimation by Transabdominal Ultrasound: Prospective Evidence of Comparative Accuracy to MRI and Transrectal Ultrasound in Prostate Cancer Early Diagnostics
by: Liza M. Kurucz, et al.
Published: (2025)

Metformin and Flutamide Combination Therapy’s Efficacy and Safety in Prostate Cancer Cell Lines
by: AhmadReza Rezaeian, et al.
Published: (2026)

Spatial Distribution of Prostate Cancer Missed by MRI‐Targeted Biopsy, Effect of a Perilesional Template, and Restaging in a Radical Prostatectomy Cohort
by: Ruth Himmelsbach, et al.
Published: (2026)

Comprehensive Genomic Profiling Testing for Castration‐Resistant Prostate Cancer in Advanced Elderly Patients: A Single‐Center Retrospective Cohort Study
by: Takafumi Fukushima, et al.
Published: (2025)

Are NCCN and EAU Active Surveillance Criteria Reliable in Patients With ISUP Grade‐2 Intermediate‐Risk Prostate Cancer? A Novel Model Integrating MRI to Predict Adverse Pathology
by: Serdar Madendere, et al.
Published: (2025)

Relationship Between Radiation Therapy and Fecal Incontinence in Patients Treated for Localized Prostate Cancer: Results of the French ICONES Study
by: Yazid Belkacemi, et al.
Published: (2025)

Androgen‐Deprivation Therapy and Dietary Habits Influence the Gut Microbial Environment in Patients With High‐Risk Localized Prostate Cancer
by: Masanori Ishida, et al.
Published: (2025)